Oral zinc for the prevention of hyperbilirubinaemia in neonates
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Zinc for the Prevention of Hyperbilirubinaemia in Neonates." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New. Accessed 20 April 2024.
Oral zinc for the prevention of hyperbilirubinaemia in neonates. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New. Accessed April 20, 2024.
Oral zinc for the prevention of hyperbilirubinaemia in neonates. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New
Oral Zinc for the Prevention of Hyperbilirubinaemia in Neonates [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral zinc for the prevention of hyperbilirubinaemia in neonates
ID - 439073
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -